AMENDMENT # 4 TO API MANUFACTURING AND SUPPLY AGREEMENTApi Manufacturing and Supply Agreement • August 7th, 2013 • Optimer Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment # 4 to API Manufacturing and Supply Agreement (this “Amendment # 4”), is entered into as of April 29, 2013 by and between Optimer Pharmaceuticals, Inc. (“Optimer”) and Biocon Limited (“Biocon”).
API MANUFACTURING AND SUPPLY AGREEMENTApi Manufacturing and Supply Agreement • June 17th, 2016 • Cempra, Inc. • Pharmaceutical preparations • New York
THIS API MANUFACTURING AND SUPPLY AGREEMENT (the “Agreement”) is entered into as of , 2015 (the “Effective Date”) by and between Cempra Pharmaceuticals, Inc., a company organized under the laws of Delaware, USA with a place of business at 6340 Quadrangle Drive, Suite 100, Chapel Hill, NC 27517, USA (“Cempra”), and FUJIFILM FINECHEMICALS CO., LTD., a company organized under the laws of Japan with a place of business at 2-3, Higashiyawata 5-chome, Hiratsuka, Kanagawa 254-0016, Japan (“FFFC”). Cempra and FFFC may be referred to herein individually as a “Party”, and collectively as the “Parties”.
API Manufacturing and Supply Agreement between Biocon Limited and Optimer Pharmaceuticals, Inc. May 18, 2010Api Manufacturing and Supply Agreement • August 4th, 2010 • Optimer Pharmaceuticals Inc • Pharmaceutical preparations
Biocon Limited, a company incorporated under the laws of India, having its registered office at 20th K.M., Hosur Road, Electronics City P.O., Bangalore 560 100, India (Biocon);
AMENDMENT TO API MANUFACTURING AND SUPPLY AGREEMENTApi Manufacturing and Supply Agreement • March 10th, 2011 • Optimer Pharmaceuticals Inc • Pharmaceutical preparations
This AMENDMENT TO API MANUFACTURING AND SUPPLY AGREEMENT (this “Amendment”), is entered into as of December 21, 2010 by and between OPTIMER PHARMACEUTICALS, INC. (“Optimer”) and BIOCON LIMITED (“Biocon”). Capitalized terms used herein which are not defined herein shall have the definitions ascribed to them in the Agreement (defined below).
API MANUFACTURING AND SUPPLY AGREEMENTApi Manufacturing and Supply Agreement • March 7th, 2013 • Cempra, Inc. • Pharmaceutical preparations • England
This API MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), effective as of the 30th day of January, 2013 (the “Effective Date”), is by and between WOCKHARDT LTD., an Indian limited company, registered under the Companies Act, 1956 with its principal offices at Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai 400051, Maharashtra, India, (“Manufacturer”), and CEMPRA PHARMACEUTICALS, INC., a North Carolina corporation with its principal offices at 6340 Quadrangle Drive # 100, Chapel Hill, NC 27517-8149 (“Cempra”) (each of Cempra and Manufacturer are referred to at times as a “Party” and collectively as the “Parties”).
API MANUFACTURING AND SUPPLY AGREEMENTApi Manufacturing and Supply Agreement • February 25th, 2016 • Cempra, Inc. • Pharmaceutical preparations • New York
This API Manufacturing and Supply Agreement (the “Agreement”) is entered into as of ________, 2015 (the “Effective Date”) by and between Cempra Pharmaceuticals, Inc., a company organized under the laws of Delaware, USA with a place of business at 6340 Quadrangle Drive, Suite 100, Chapel Hill, NC 27517, USA (“Cempra”), and FUJIFILM Finechemicals Co., Ltd., a company organized under the laws of Japan with a place of business at 2-3, Higashiyawata 5-chome, Hiratsuka, Kanagawa 254-0016, Japan (“FFFC”). Cempra and FFFC may be referred to herein individually as a “Party”, and collectively as the “Parties”.
THIRD AMENDMENT TO API MANUFACTURING AND SUPPLY AGREEMENTApi Manufacturing and Supply Agreement • November 2nd, 2012 • Optimer Pharmaceuticals Inc • Pharmaceutical preparations
This Third Amendment (this “Third Amendment”) dated as of the 10th day of September, 2012 (the “Third Amendment Date”), is made by and between Biocon Limited (“Biocon”) and Optimer Pharmaceuticals, Inc. (“Optimer”).
AMENDMENT TO API MANUFACTURING AND SUPPLY AGREEMENTApi Manufacturing and Supply Agreement • August 3rd, 2012 • Optimer Pharmaceuticals Inc • Pharmaceutical preparations
This AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT (this “Amendment”), is entered into as of May 20, 2011 by and between OPTIMER PHARMACEUTICALS, INC. (“Optimer”) and BIOCON LIMITED (“Biocon”). Capitalized terms used herein which are not defined herein shall have the definitions ascribed to them in the Agreement (defined below).
